Form 4: Tyra Biosciences CEO Boosts Stake via ESPP

Tyra Biosciences President and CEO, Todd Harris, acquired 1,463 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• Todd Harris, President and CEO of Tyra Biosciences, Inc. (TYRA), acquired 1,463 shares of common stock.
• The transaction occurred on March 13, 2026, at a price of $9.129 per share.
• These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan (ESPP).
• Following this transaction, Todd Harris beneficially owns a total of 1,358,631 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating management's confidence in the company's valuation and future performance through a direct investment.

Positives

• An insider, the President and CEO, acquired additional shares, which can signal confidence in the company's future performance.
• The acquisition was made through an Employee Stock Purchase Plan, indicating participation in a broad-based employee benefit program.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider purchases, especially by top executives like a President and CEO, are often interpreted by the market as a positive signal, indicating management's belief in the company's intrinsic value and future growth prospects. This aligns with broader trends where management's alignment of interests with shareholders is viewed favorably.

Comparison to Industry Standards

• Employee Stock Purchase Plans (ESPPs) are a common benefit offered by publicly traded companies across various industries, including biotechnology, to allow employees to purchase company stock at a discount, fostering employee ownership and alignment.
• Insider buying activity, particularly by C-suite executives, is a widely tracked metric by investors, often seen as a stronger indicator of confidence than purchases by non-executive employees or directors.

Stakeholder Impact

• Shareholders may view the CEO's purchase as a positive sign of management's confidence in the company's future, potentially boosting investor sentiment.
• Employees participating in the ESPP benefit from the opportunity to purchase company stock at a favorable price, aligning their financial interests with the company's success.

Key Dates

Recommendation

The CEO's direct purchase of shares through an Employee Stock Purchase Plan signals strong confidence in Tyra Biosciences' future prospects and valuation, aligning management's interests with shareholders. This insider buying activity is generally considered a positive indicator for investors.

Keywords

Tyra Biosciences, TYRA, Todd Harris, Insider Trading, Stock Purchase, ESPP, Form 4, Common Stock, CEO